These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15072250)

  • 1. Inhibition of neutrophil activity in cardiac surgery with cardiopulmonary bypass: a novel strategy with the leukocyte inhibition module.
    Moreno JB; Margraf S; Schuller AM; Simon A; Moritz A; Scholz M
    Perfusion; 2004 Jan; 19(1):11-6. PubMed ID: 15072250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model.
    Scholz M; Simon A; Berg M; Schuller AM; Hacibayramoglu M; Margraf S; Theisen A; Windolf J; Wimmer-Greinecker G; Moritz A
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1735-42. PubMed ID: 15173731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First efficacy and safety results with the antibody containing leukocyte inhibition module in cardiac surgery patients with neutrophil hyperactivity.
    Scholz M; Cinatl J; Barros RT; Lisboa AC; Genevcius CF; Margraf S; Francischetti I; Oremek G; Windolf J; Simon A; Moritz A; Bitu-Moreno J
    ASAIO J; 2005; 51(2):144-7. PubMed ID: 15839438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report.
    Di Salvo C; Louca LL; Pattichis K; Hooper J; Walesby RK
    J Cardiovasc Surg (Torino); 1996 Dec; 37(6 Suppl 1):93-100. PubMed ID: 10064358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit.
    Gu YJ; de Vries AJ; Vos P; Boonstra PW; van Oeveren W
    Ann Thorac Surg; 1999 Mar; 67(3):604-9. PubMed ID: 10215195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study.
    Mihaljevic T; Tönz M; von Segesser LK; Pasic M; Grob P; Fehr J; Seifert B; Turina M
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1138-45. PubMed ID: 7776678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a new oxygenator-integrated fat and leukocyte removal device.
    Dell'Amore A; Tripodi A; Cavallucci A; Guerrini F; Ronchi B; Zanoni S; Lamarra M
    Asian Cardiovasc Thorac Ann; 2010 Dec; 18(6):546-50. PubMed ID: 21149403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation.
    Gott JP
    Perfusion; 2001 Mar; 16 Suppl():5-9. PubMed ID: 11334206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte filtration in cardiac surgery: a review.
    Matheis G; Scholz M; Simon A; Dzemali O; Moritz A
    Perfusion; 2001 Sep; 16(5):361-70. PubMed ID: 11565891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial.
    Lust RM; Bode AP; Yang L; Hodges W; Chitwood WR
    ASAIO J; 1996; 42(5):M819-22. PubMed ID: 8944997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of leukocyte filtration during cardiopulmonary bypass.
    Matheis G; Scholz M; Simon A; Henrich D; Wimmer-Greinecker G; Moritz A
    Perfusion; 2001 Mar; 16 Suppl():31-7. PubMed ID: 11334204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass.
    Abdel-Rahman U; Margraf S; Aybek T; Lögters T; Bitu-Moreno J; Francischetti I; Kranert T; Grünwald F; Windolf J; Moritz A; Scholz M
    J Inflamm (Lond); 2007 Oct; 4():21. PubMed ID: 17925040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory response to CPB: the role of leukocyte filtration.
    Asimakopoulos G
    Perfusion; 2002 May; 17 Suppl():7-10. PubMed ID: 12009089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass.
    Olivencia-Yurvati AH; Ferrara CA; Tierney N; Wallace N; Mallet RT
    Perfusion; 2003 Mar; 18 Suppl 1():23-31. PubMed ID: 12708762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for reduction in morbidity and cost with total leucocyte control for cardiac surgery.
    Ortolano GA
    Perfusion; 1995 Sep; 10(5):283-90. PubMed ID: 8601039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome?
    Efstathiou A; Vlachveis M; Tsonis G; Asteri T; Psarakis A; Fessatidis IT
    J Cardiovasc Surg (Torino); 2003 Apr; 44(2):197-204. PubMed ID: 12813383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.